Registration No. |
国药准字SJ20200023 |
Registration No. Remarks |
申请人应按照《药品标准物质原料申报备案办法》向中检院报送标准物质原料以及有关物质研究资料 |
Drug Name(Chinese) |
甘精胰岛素注射液 |
Drug Name(English) |
Insulin Glargine Solution for Injection |
Drug Sandard Code(Chines) |
86978820000824 |
Manufacturers(English) |
Sanofi-aventis Deutschland GmbH |
Production Address(English) |
Industriepark Hoechst, Brueningstrasse 50,D-65926 Frankfurt am Main,Germany |
State(Chinese) |
德国 |
State(English) |
Germany |
Dosage Form |
注射剂 |
Strength |
1.5ml:450单位/预填充式注射笔 |
Packaging |
1支/盒,3支/盒;2888支/箱 |
Date Issued |
2020-09-02 |
Valid Until |
2025-09-01 |
Category |
生物制品 |